PLA2R1 and nephrotic syndrome: In contrast, the absence of anti-PLA2R antibodies in the vast majority of patients with MN indicates the secondary cause of nephrotic syndrome, i.e., the malignancy, and thus may be very helpful in terms of clinical management to identify those patients with MN who need a more extensive workup for malignancies.